(VIANEWS) – SCATEC (SCATC.OL), AF GRUPPEN (AFG.OL), FLEX LNG (FLNG.OL) are the highest payout ratio stocks on this list.
We have gathered information about stocks with the highest payout ratio at the moment. The payout ratio in itself isn’t a promise of good investment but it’s an indicator of whether dividends are being paid and how the company chooses to distribute them.
When investigating a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.
1. SCATEC (SCATC.OL)
923.81% Payout Ratio
Scatec ASA, together with its subsidiaries, provides renewable energy solutions worldwide. The company operates through Power Production; Services; and Development & Construction segments. It develops, builds, owns, and operates solar, wind, and hydro power plants and storage solutions. The company is also involved in the engineering, procurement, construction, operation, maintenance, and asset management of power plants. It has a total of 4.6 GW in operation and under construction. The company was formerly known as Scatec Solar ASA and changed its name to Scatec ASA in November 2020. Scatec ASA was incorporated in 2007 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, SCATEC has a trailing twelve months EPS of kr-1.11.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -0.35%.
Yearly Top and Bottom Value
SCATEC’s stock is valued at kr63.10 at 11:10 EST, way below its 52-week high of kr92.80 and way above its 52-week low of kr52.50.
Earnings Before Interest, Taxes, Depreciation, and Amortization
SCATEC’s EBITDA is 9.8.
Moving Average
SCATEC’s value is higher than its 50-day moving average of kr62.04 and way under its 200-day moving average of kr70.77.
More news about SCATEC.
2. AF GRUPPEN (AFG.OL)
139.44% Payout Ratio
AF Gruppen ASA, a contracting and industrial company, provides civil engineering, environmental, construction, property, energy, and offshore services in Norway and Sweden. It offers civil engineering services including construction of various projects, such as roads, rail, airports, foundation work, building, fitting, and securing tunnels; and oil and gas installation services, and port facilities, as well as provides concrete technology, groundwork and earthmoving, geomatics and surveying, and project support services. The company also operates as a turnkey contractor that includes development and planning to buildings comprising residential, commercial, public buildings, and rehabilitation and rebuilding, as well as offers extension work services. In addition, it provides energy solutions, which includes energy performing contracting, technical turnkey contract, local power supply, and technical services and maintenance, as well as energy solutions for existing and new buildings. Further, the company engages in operation of construction and decommissioning projects including removal and recycling of offshore installations; and offers cooling and ventilation for onshore and offshore installations, rigs, and ships, as well as offshore wind services. It also operates as a contractor for demolition and environmental clean-up services for buildings and structures, such as blasting, dredging, handling of contaminated bulk material, and removal of shipwrecks. Additionally, the company provides office spaces on rental basis, and sale of homes. AF Gruppen ASA was founded in 1985 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, AF GRUPPEN has a trailing twelve months EPS of kr6.58.
PE Ratio
AF GRUPPEN has a trailing twelve months price to earnings ratio of 17.08. Meaning, the purchaser of the share is investing kr17.08 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 27.7%.
More news about AF GRUPPEN.
3. FLEX LNG (FLNG.OL)
112.36% Payout Ratio
Flex LNG Ltd., together with its subsidiaries, engages in the seaborne transportation of liquefied natural gas (LNG) worldwide. The company owns and operates vessels with M-type electronically controlled gas injection LNG carriers; and vessels with generation X dual fuel propulsion systems. It also provides chartering services. Flex LNG Ltd. was incorporated in 2006 and is based in Hamilton, Bermuda.
Earnings Per Share
As for profitability, FLEX LNG has a trailing twelve months EPS of kr29.55.
PE Ratio
FLEX LNG has a trailing twelve months price to earnings ratio of 11.65. Meaning, the purchaser of the share is investing kr11.65 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.13%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
FLEX LNG’s EBITDA is 88.24.
Sales Growth
FLEX LNG’s sales growth is 9.5% for the current quarter and negative 0.3% for the next.
More news about FLEX LNG.
4. TUBIZE-FIN (TUB.BR)
43.03% Payout Ratio
Financière de Tubize SA, through its interest in UCB, operates as a biopharmaceutical company worldwide. It discovers and develops medicines and solutions in the therapeutic areas of neurology and immunology diseases. The company's products include Cimzia for treating ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Briviact, Vimpat, and Keppra for the treatment of epilepsy partial-onset seizures; Nayzilam, a nasal spray; and Neupro for treating Parkinson's disease and restless legs syndrome. It also offers Evenity, an injection for osteoporosis; and Bimzelx to treat moderate to severe plaque psoriasis. The company's products in pipeline include Staccato to treat stereotypical prolonged seizures; Bepranemab for the treatment of Alzheimer's disease; UCB0599 for Parkinson's disease; bimekizumab to treat psoriasis, psoriatic arthritis, hidradenitis suppurativa, and axial spondyloarthritis; rozanolixizumab to treat myasthenia gravis, immune thrombocytopenia, myelin oligodendrocyte glycoprotein antibody disease, and autoimmune encephalitis; and dapirolizumab pegol for systemic lupus erythematosus. Financière de Tubize SA is based in Brussels, Belgium.
Earnings Per Share
As for profitability, TUBIZE-FIN has a trailing twelve months EPS of €2.
PE Ratio
TUBIZE-FIN has a trailing twelve months price to earnings ratio of 30.55. Meaning, the purchaser of the share is investing €30.55 for every euro of annual earnings.
Volume
Today’s last reported volume for TUBIZE-FIN is 4756 which is 35.55% below its average volume of 7380.
Moving Average
TUBIZE-FIN’s value is under its 50-day moving average of €67.67 and way below its 200-day moving average of €72.39.
Yearly Top and Bottom Value
TUBIZE-FIN’s stock is valued at €61.10 at 11:10 EST, way under its 52-week high of €79.90 and higher than its 52-week low of €60.80.
More news about TUBIZE-FIN.
1. 1 (1)
1% Payout Ratio
1
Earnings Per Share
As for profitability, 1 has a trailing twelve months EPS of €1.
PE Ratio
1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing €1 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 1% and 1%, respectively.
Volatility
1’s last week, last month’s, and last quarter’s current intraday variation average was 1.00%, 1.00%, and 1.00%.
1’s highest amplitude of average volatility was 1.00% (last week), 1.00% (last month), and 1.00% (last quarter).
More news about 1.
